Pharma Emissions Reduction Targets
Sandoz Earned SBTi Validation for Its Greenhouse Gas Reduction
Adam Harrie — May 11, 2026
Sandoz received validation from the Science Based Targets initiative for its greenhouse gas reduction goals, committing to a 42% cut in Scope 1 and 2 emissions by 2030 and 63% by 2035 against a 2024 baseline. The science-based emissions targets validation also requires at least 79% of Sandoz suppliers by emissions to have their own science-based targets by 2030.
The company has already reduced its absolute emissions by 3% and emissions intensity by 15% between 2023 and 2025. Its decarbonization roadmap includes energy efficiency, renewable energy, packaging circularity, logistics optimization and supplier partnerships.
As pharmaceutical companies continue aligning with global climate pathways, Sandoz shows how validated emissions targets can strengthen credibility while building the operational discipline needed to deliver on long-term climate commitments.
